Showing results (181-190 of 237) with videos related to
Sort By:
Pageof 24
Science (New York, N.Y.)|November 3, 1995
Aberrant subcellular localization of BRCA1 in breast cancerY Chen, C F Chen, D J Riley, et al.Breast Cancer Research and Treatment|November 6, 2012
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-upL Malorni, P B Shetty, C De Angelis, et al.Cancer Research|September 1, 1988
Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosisC L Arteaga, A R Hanauske, G M Clark, et al.Molecular Endocrinology (Baltimore, Md.)|March 9, 2000
Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivationS Oesterreich, Q Zhang, T Hopp, et al.Journal of the National Cancer Institute|February 3, 1993
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancerD C Allred, G M Clark, R Elledge, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patientsS Oesterreich, S G Hilsenbeck, D R Ciocca, et al.The EMBO Journal|March 15, 1994
The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancerD Stein, J Wu, S A Fuqua, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancerP M Ravdin, A K Tandon, D C Allred, et al.Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 6, 2024
Second Victim Experiences of Health Care Learners and the Influence of the Training Environment on Postevent AdaptationLily Huang, Kirsten A Riggan, Vanessa E Torbenson, et al.European Journal of Cancer & Clinical Oncology|May 1, 1987
Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agentsA R Hanauske, C K Osborne, G C Chamness, et al.Pageof 24